Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Whiteman

Showing results (131-140 of 154) with videos related to

Pageof 16
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|June 26, 2016
Cardioprotection by H2S Donors: Nitric Oxide-Dependent and ‑Independent MechanismsAthanasia Chatzianastasiou, Sofia-Iris Bibli, Ioanna Andreadou, et al.
Shock (Augusta, Ga.)|January 21, 2017
Metabolic, Cardiac, and Renal Effects of the Slow Hydrogen Sulfide-Releasing Molecule GYY4137 During Resuscitated Septic Shock in Swine with Pre-Existing Coronary Artery DiseaseBenedikt L Nußbaum, Josef Vogt, Ulrich Wachter, et al.
Neuropharmacology|July 27, 2025
The mitochondria-targeted hydrogen sulfide donor AP39 reduces cortical stroke volume and improves motor function in a photothrombotic stroke model in mice in a sex-dependent mannerJakub Jurczyk, Zuzanna Guzda, Alicja Skórkowska, et al.
Nitric Oxide : Biology and Chemistry|January 4, 2015
Effects of AP39, a novel triphenylphosphonium derivatised anethole dithiolethione hydrogen sulfide donor, on rat haemodynamic parameters and chloride and calcium Cav3 and RyR2 channelsLenka Tomasova, Michaela Pavlovicova, Lubica Malekova, et al.
Pharmacological Research|September 20, 2024
Mitochondria-targeted hydrogen sulfide donor reduces fatty liver and obesity in mice fed a high fat diet by inhibiting de novo lipogenesis and inflammation via mTOR/SREBP-1 and NF-κB signaling pathwaysAneta Stachowicz, Klaudia Czepiel, Anna Wiśniewska, et al.
Pharmaceuticals (Basel, Switzerland)|October 23, 2021
The Hypothermic Effect of Hydrogen Sulfide Is Mediated by the Transient Receptor Potential Ankyrin-1 Channel in MiceEmoke Olah, Zoltan Rumbus, Viktoria Kormos, et al.
British Journal of Pharmacology|April 25, 2019
Hydrogen sulfide inhibits calcification of heart valves; implications for calcific aortic valve diseaseKatalin Éva Sikura, László Potor, Tamás Szerafin, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 12, 2021
Hydrogen sulfide is neuroprotective in Alzheimer's disease by sulfhydrating GSK3β and inhibiting Tau hyperphosphorylationDaniel Giovinazzo, Biljana Bursac, Juan I Sbodio, et al.
Journal of Neurochemistry|June 15, 2006
Chronic exposure to U18666A is associated with oxidative stress in cultured murine cortical neuronsChor Hui Vivien Koh, Matthew Whiteman, Qiao-Xin Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 31, 2023
Mitochondrial sulfide promotes life span and health span through distinct mechanisms in developing versus adult treated <i>Caenorhabditis elegans</i>Adriana Raluca Vintila, Luke Slade, Michael Cooke, et al.
Pageof 16

Showing results (131-140 of 154) with videos related to

Sort By:
Pageof 16
The Journal of Pharmacology and Experimental Therapeutics|June 26, 2016
Cardioprotection by H2S Donors: Nitric Oxide-Dependent and ‑Independent MechanismsAthanasia Chatzianastasiou, Sofia-Iris Bibli, Ioanna Andreadou, et al.
Shock (Augusta, Ga.)|January 21, 2017
Metabolic, Cardiac, and Renal Effects of the Slow Hydrogen Sulfide-Releasing Molecule GYY4137 During Resuscitated Septic Shock in Swine with Pre-Existing Coronary Artery DiseaseBenedikt L Nußbaum, Josef Vogt, Ulrich Wachter, et al.
Neuropharmacology|July 27, 2025
The mitochondria-targeted hydrogen sulfide donor AP39 reduces cortical stroke volume and improves motor function in a photothrombotic stroke model in mice in a sex-dependent mannerJakub Jurczyk, Zuzanna Guzda, Alicja Skórkowska, et al.
Nitric Oxide : Biology and Chemistry|January 4, 2015
Effects of AP39, a novel triphenylphosphonium derivatised anethole dithiolethione hydrogen sulfide donor, on rat haemodynamic parameters and chloride and calcium Cav3 and RyR2 channelsLenka Tomasova, Michaela Pavlovicova, Lubica Malekova, et al.
Pharmacological Research|September 20, 2024
Mitochondria-targeted hydrogen sulfide donor reduces fatty liver and obesity in mice fed a high fat diet by inhibiting de novo lipogenesis and inflammation via mTOR/SREBP-1 and NF-κB signaling pathwaysAneta Stachowicz, Klaudia Czepiel, Anna Wiśniewska, et al.
Pharmaceuticals (Basel, Switzerland)|October 23, 2021
The Hypothermic Effect of Hydrogen Sulfide Is Mediated by the Transient Receptor Potential Ankyrin-1 Channel in MiceEmoke Olah, Zoltan Rumbus, Viktoria Kormos, et al.
British Journal of Pharmacology|April 25, 2019
Hydrogen sulfide inhibits calcification of heart valves; implications for calcific aortic valve diseaseKatalin Éva Sikura, László Potor, Tamás Szerafin, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 12, 2021
Hydrogen sulfide is neuroprotective in Alzheimer's disease by sulfhydrating GSK3β and inhibiting Tau hyperphosphorylationDaniel Giovinazzo, Biljana Bursac, Juan I Sbodio, et al.
Journal of Neurochemistry|June 15, 2006
Chronic exposure to U18666A is associated with oxidative stress in cultured murine cortical neuronsChor Hui Vivien Koh, Matthew Whiteman, Qiao-Xin Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 31, 2023
Mitochondrial sulfide promotes life span and health span through distinct mechanisms in developing versus adult treated <i>Caenorhabditis elegans</i>Adriana Raluca Vintila, Luke Slade, Michael Cooke, et al.
Pageof 16